Should Tamoxifen Be Used in Breast Cancer Prevention? Rita KramerPowel Brown Current Opinion 20 November 2012 Pages: 979 - 989
Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents Ian C.K. WongFrank M.C. BesagMacey L. Murray Review Article 20 November 2012 Pages: 991 - 1000
Safety of a New Oral Contraceptive Containing Drospirenone Lothar A.J. HeinemannJürgen Dinger Review Article 20 November 2012 Pages: 1001 - 1018
Treatment Costs to Prevent or Treat Upper Gastrointestinal Adverse Events Associated with NSAIDs Elham RahmeAlan N. BarkunMarc Bardou Review Article 20 November 2012 Pages: 1019 - 1042
Benefit-Risk Assessment of Tolterodine in the Treatment of Overactive Bladder in Adults Alan D. GarelyLara Burrows Review Article 20 November 2012 Pages: 1043 - 1057
The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric Patients Antje NeubertHarald DormannBurkhard Hinz Original Research Article 20 November 2012 Pages: 1059 - 1067